Soluble products of inflammatory reactions are not induced in children with asymptomatic Plasmodium falciparum infections

Clinical and Experimental Immunology

Volumn 105, Issue 1, 1996, Pages 69-73

  Jakobsen, P H ^a   Mckay, V ^b   N'Jie, R ^b   Olaleye, B O ^b   D'Alessandro, U ^b   Bendtzen, K ^a   Schousboe, I ^c   Greenwood, B M ^b  

^a Rigshospitalet   (Denmark)

^b MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

asymptomatic infection; cytokines; malaria; Plasmodium falciparum; 2 glycoprotein I

Indexed keywords

BETA2 GLYCOPROTEIN 1; CHLOROQUINE; CYTOKINE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4 RECEPTOR; PHOSPHOLIPID ANTIBODY; TOXIN;

ARTICLE; BLOOD SMEAR; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALARIA; MALE; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL;

EID: 0030015622     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1996.d01-718.x     Document Type: Article

References (18)

1. Greenwood BM, Marsh K, Snow R. Why do some African children develop severe malaria? Parasitol Today 1987; 7:277-81.
2. Marsh K. Malaria - a neglected disease? Parasitol 1992; 104 (Suppl.): s53-s69.
3. Playfair JHL, Taverne J, Bate CAW, de Souza JB. The malaria vaccine: anti-parasite or anti-disease? Immunol Today 1990; 11:25-27.
4. Bate CAW, Taverne J, Playfair JHL. Malarial parasites induce TNF production by macrophages. Immunol 1988; 64:227-31.
5. Kwiatkowski D, Cannon JG, Manogue KR, Cerami A, Dinarello CA, Greenwood BM. Tumour necrosis factor production in Falciparum malaria and its association with schizont rupture. Clin Exp Immunol 1989; 77:361-6.
6. Greenwood BM, Armstrong JRM. Comparison of two simple methods for determining malaria parasite density. Trans R Soc Trop Med Hyg 1991; 85:186-8.
7. Jakobsen PH, McKay V, Morris-Jones SD et al. Increased concentrations of interleukin-6 and interleukin-1 receptor antagonist and decreased concentrations of beta-2-glycoprotein I in Gambian children with cerebral malaria. Infect Immun 1994; 62:4374-9.
8. Jakobsen PH, Morris-Jones S, Theander TG et al. Increased plasma levels of soluble 1L-2R are associated with severe Plasmodium falciparum malaria. Clin Exp Immunol 1994; 96:98-103.
9. Schousboe I. Addition of deoxycholate in electroimmunoassay and crossed immunofocusing for quantification of beta-2-glycoprotein I and its subfractions. J Biochem Biophys Methods 1982; 6:105-14.
10. Jakobsen PH, Morris-Jones SD, Hviid L, Theander TG, Høier-Madsen M, Bayoumi RAL, Greenwood BM. Anti-phospholipid antibodies in patients with Plasmodium falciparum malaria. Immunol 1993; 79:653-7.
11. Peyron F, Burdin N, Ringwald P, Vuillez JP, Rousset F, Banchereau J. High levels of circulating IL-10 in human malaria. Clin Exp Immunol 1994; 95:300-3.
12. Allan RJ, Rowe A, Kwiatkowski D. Plasmodium falciparum varies in its ability to induce tumor necrosis factor. Infect Immun 1993; 61:4772-6.
13. McGuire W, Hill AVS, Allsopp CEM, Greenwood BM, Kwiatkowski D. Variation in the TNF-alpha promotor region associated with susceptibility to cerebral malaria. Nature 1994; 371:508-11.
14. Jakobsen PH, Bate CAW, Taverne J, Playfair JHL. Malaria: toxins, cytokines and disease. Parasite Immunol 1995; 17:223-31.
15. Bate CAW, Taverne J, Playfair JHL. Detoxified exoantigens and phosphatidylinositol derivatives inhibit tumour necrosis factor induction by malarial exoantigens. Infect Immun 1992; 60:1894-901.
16. Bate CAW, Taverne J, Bootsma HJ, Mason RC, Skalko N, Gregoriadidis G, Playfair JHL. Antibodies against phosphatidylinositol and inositol monophosphate specifically inhibit tumour necrosis factor induction by malaria exoantigens. Immunol 1992; 76:35-41.
17. Bate CAW, Kwiatkowski D. Inhibitory immunoglobulin M anti-bodies to tumor necrosis factor-inducing toxins in patients with malaria. Infect Immun 1994; 62:3086-91.
18. Facer CA, Agiostratidou G. High levels of anti-phospholipid anti-bodies in uncomplicated and severe Plasmodium falciparum and in P. vivax malaria. Clin Exp Immunol 1995; 95:304-9.